The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murray, D. A.
Right arrow Articles by Crispe, I. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, D. A.
Right arrow Articles by Crispe, I. N.
The Journal of Immunology, 2004, 173: 2402-2409.
Copyright © 2004 by The American Association of Immunologists

TNF-{alpha} Controls Intrahepatic T Cell Apoptosis and Peripheral T Cell Numbers1

Debbie A. Murray and I. Nicholas Crispe2

David H. Smith Center for Vaccine Biology and Immunology, Aab Institute of Biomedical Sciences, University of Rochester, Rochester, NY 14642

At the end of an immune response, activated lymphocyte populations contract, leaving only a small memory population. The deletion of CD8+ T cells from the periphery is associated with an accumulation of CD8+ T cells in the liver, resulting in both CD8+ T cell apoptosis and liver damage. After adoptive transfer and in vivo activation of TCR transgenic CD8+ T cells, an increased number of activated CD8+ T cells was observed in the lymph nodes, spleen, and liver of mice treated with anti-TNF-{alpha}. However, caspase activity was decreased only in CD8+ T cells in the liver, not in those in the lymphoid organs. These results indicate that TNF-{alpha} is responsible for inducing apoptosis in the liver and suggest that CD8+ T cells escaping this mechanism of deletion can recirculate into the periphery.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Anderson and J. Borlak
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Singh and M. Suresh
A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory
J. Leukoc. Biol., November 1, 2007; 82(5): 1201 - 1211.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.